Will CF Industries report FY2026 adjusted EBITDA above $2.5 billion?

FY2025 EBITDA was $2.9B and Q4 2025 adjusted EBITDA was $821M (annualized ~$3.3B). The $2.5B threshold is management's own mid-cycle guide, which by definition should be exceeded more often than not during above-mid-cycle conditions. The critical question is whether current conditions persist for enough of 2026. H1 2026 likely benefits from elevated nitrogen prices ($450 urea) and strong Q1 seasonal demand. Management expects H2 correction but hasn't specified magnitude. If H1 delivers ~$1.5B EBITDA (consistent with current run rate), H2 would only need $1.0B to exceed $2.5B — even a 35% decline from H1 pace. Yazoo City production loss (-600K tons) is a headwind but BI insurance may offset. I estimate 62% probability.

The math favors above $2.5B unless the correction is severe. Q1 2026 is typically the strongest quarter for nitrogen (spring planting). At current urea prices, Q1 alone could deliver $700-800M EBITDA. Q2 typically sees seasonal softening but remains solid. The risk is concentrated in Q3-Q4 — if urea drops from $450 to $350 (a $100 decline), H2 EBITDA could compress to $1.0-1.2B range. Total year would still be $2.5-2.7B in that scenario. A more severe drop to $300 would push FY2026 below $2.5B, but $300 urea is a deep trough scenario. The $2.5B threshold is at management's mid-cycle, which is designed to be a central tendency — more likely to be above than below in the near term.

I weight the structural supply tightness that management described — 'new capacity has been delayed, global production has not maintained historical levels and demand continues to grow.' This suggests the correction may be more seasonal/modest than structural. A seasonal correction from $450 to $400 in H2 would keep FY2026 comfortably above $2.5B. The $2.5B threshold only breaches if urea drops below ~$350 AND stays there through Q4. The 9.5M ton production guidance (Yazoo impact) is a headwind, but if pricing holds, the per-unit margin is large enough. BI insurance recovery timing matters — if some books in 2026, it supports EBITDA.

FY2025 at $2.9B provides a strong starting point. The $2.5B threshold is 14% below FY2025. For FY2026 to fall below $2.5B requires a meaningful and sustained correction — not just seasonal softening. The Yazoo City production loss (~$200M EBITDA impact) is partially offset by insurance. If we assume H1 EBITDA of $1.4-1.5B (moderate decline from H1 2025 pace due to Yazoo) and H2 of $1.0-1.2B (correction), the range is $2.4-2.7B. The $2.5B threshold falls within this range, making it a close call. Slightly above coin-flip because the threshold is below the prior year and structural supports remain.

I weight management's correction warning more heavily than some peers. When a commodity company CEO says 'there will be a correction in the back half,' they typically see order book softening or customer behavior changes that aren't yet in spot prices. If the correction is more severe than seasonal (e.g., China relaxes exports partially, geopolitical premium deflates), H2 could deliver only $900M-1.0B. Combined with Yazoo drag in H1, the year could come in at $2.3-2.5B. But the $2.5B threshold is management's own mid-cycle guide — they're unlikely to miss their own benchmark in a year that started with peak pricing. Slight edge to above.

The question is binary at exactly $2.5B — management's mid-cycle guide. In practice, companies that define a 'mid-cycle' typically operate above it for extended periods before a sharp reversion. CF has been above mid-cycle since at least 2021. The inertia of above-cycle operations — existing contracts, strong Q1 demand, structural supply tightness — makes it more likely FY2026 stays above than falls below. The key scenario for sub-$2.5B is a compound event: severe price correction + Yazoo production loss + no BI insurance recovery in 2026. Each individual factor is addressable; the compound scenario is less likely.

FY2025 at $2.9B. Threshold is $2.5B (14% decline). H1 2026 should be strong at current prices. Management expects H2 correction but $2.5B is their own mid-cycle. Likely above $2.5B unless severe correction. 60% probability.

Yazoo City drag and H2 correction create headwinds. But Q1 strength and structural supply tightness provide offset. $2.5B is achievable even with moderate correction. Slightly above coin-flip at 58%.

The bar at $2.5B is management's mid-cycle, and we're entering 2026 at peak. Even with reversion toward mid-cycle, the full-year average is likely above mid-cycle if H1 stays elevated. The math favors above $2.5B unless H2 is much worse than management suggests. 63%.